The European Medicines Agency will convene a meeting on Dec.
Health industry responds to European Innovation Partnership proposal
Leaders from across the health sector released a joint statement
Theravance Biopharma and Mylan to Report New Data from Phase 3 Studies of Yupelri (revefenacin) in Oral Presentation at European Respiratory Society International Congress 2018
DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Sept. 11, 2018 /PRNewswire/